Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.310
+0.005 (0.12%)
Nov 21, 2024, 10:47 AM EST - Market open
Achieve Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 148 | 87 | 44 | 74 | 49 | 11 | |
Market Cap Growth | 79.36% | 98.88% | -40.38% | 51.52% | 337.66% | 36.38% | |
Enterprise Value | 115 | 84 | 41 | 40 | 26 | 4 | |
Last Close Price | 4.30 | 4.12 | 2.45 | 7.78 | 8.10 | 10.60 | |
PB Ratio | 4.72 | -60.22 | 5.28 | 2.62 | 1.30 | 0.61 | |
P/TBV Ratio | 5.55 | - | 7.49 | 2.90 | 1.41 | 0.74 | |
Debt / Equity Ratio | 0.31 | -11.55 | 1.95 | 0.53 | 0.00 | 0.02 | |
Quick Ratio | 6.39 | 0.75 | 1.15 | 9.49 | 12.22 | 5.81 | |
Current Ratio | 6.78 | 0.82 | 1.27 | 9.80 | 12.60 | 6.04 | |
Return on Equity (ROE) | -186.03% | -869.88% | -233.04% | -101.49% | -53.24% | -96.86% | |
Return on Assets (ROA) | -54.09% | -69.03% | -65.82% | -47.11% | -30.04% | -51.44% | |
Return on Capital (ROIC) | -63.51% | -85.62% | -75.52% | -51.44% | -33.05% | -60.38% | |
Earnings Yield | -22.25% | -34.19% | -96.58% | -45.07% | -30.35% | -147.82% | |
FCF Yield | -16.85% | -28.10% | -85.68% | -40.03% | -27.79% | -137.67% | |
Buyback Yield / Dilution | -60.31% | -87.17% | -30.46% | -198.64% | -559.42% | -134.93% | |
Total Shareholder Return | -60.31% | -87.17% | -30.46% | -198.64% | -559.42% | -134.93% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.